Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Cleveland, OH
NPI: 1104960525Primary Practice Location
UH REGIONAL HOSPITALS
27100 Chardon Rd, Richmond Heights, OH
Primary Employer
University Hospitals Medical Group Inc
uhhospitals.org
HQ Phone
Get M.D. Prateek's Phone NumberMobile
Get M.D. Prateek's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardSC State Medical License
OH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 147 | 244 |
| 2 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 43 | 63 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 42 | 59 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 13 | 17 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 11 | 26 |
Organ Preservation for Recurrent Urethral Adenocarcinoma With Concurrent Chemotherapy and Radiation.
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Authors: Petros Grivas
Journal: Target Oncol
Authors: Ahmad Tarhini
Publication Date: 2018-07-04
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Degarelix, DRUG: Bicalutamide, DRUG: Flutamide, DRUG: Goserelin Acetate, DRUG: Leuprolide Acetate, DRUG: Leuprolide, DRUG: Goserelin, DRUG: Nilutamide
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Prednisone, DRUG: Antiandrogen Therapy, DRUG: Cabazitaxel, DRUG: Abiraterone Acetate, PROCEDURE: Orchiectomy
Lead Sponsor: University Hospitals Cleveland Medical Center
Intervention / Treatment: OTHER: COVID antibody titers in the blood
